Final study results show Pfizer’s experimental COVID-19 pill remained as effective as indicated by preliminary data last month, a major relief after promising data for …

An experimental hemophilia drug cut bleeding episodes by 90% in patients who took it when compared to those given standard treatments in a late-stage clinical …